Albert Cha
Vermogen: 835 930 $ op 31-05-2026
Vermogen: 835 930 $ op 31-05-2026
Albert Cha bekleedt de functie van Managing Partner bij Frazier Management LLC. Hij zit ook in de raad van bestuur van 6 andere bedrijven. Voordien bekleedde hij de functie van consultant bij Oracle Corp. en Managing Partner bij Vivo Capital LLC. Hij behaalde een doctoraat en een undergraduaat aan de Stanford University, een doctoraat aan de David Geffen School of Medicine en een doctoraat aan de University of California, Los Angeles.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ASCENDIS PHARMA A/S 0,01% | 18-03-2026 | 3.730 ( 0,01% ) | 835 930 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ASCENDIS PHARMA A/S | Voorzitter | 28-05-2021 |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Private Equity Investor | 01-02-2021 |
KalVista Pharmaceuticals Ltd.
KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral medicines | Directeur/Bestuurslid | - |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Directeur/Bestuurslid | - |
Neomend, Inc.
Neomend, Inc. BiotechnologyHealth Technology Develops surgical wound healing products | Directeur/Bestuurslid | 29-01-2010 |
| Bedrijven | Functie | Einde |
|---|---|---|
| KALVISTA PHARMA | Directeur/Bestuurslid | 03-10-2024 |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Private Equity Investor | 30-11-2020 |
| VYNE THERAPEUTICS INC. | Directeur/Bestuurslid | 19-03-2019 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Directeur/Bestuurslid | 07-09-2018 |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 30 |
|---|---|
Oracle Corp.
Oracle Corp. Packaged SoftwareTechnology Services Provides cloud based enterprise applications and infrastructure technologies & license, hardware and IT services | Technology Services |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
Vivo Capital LLC
Vivo Capital LLC Investment ManagersFinance Vivo Capital invests in both public and private middle-market companies located across the globe. The firm targets companies operating in the fields of biotechnology, pharmaceutical, healthcare and life sciences. It provides financing for early stage, growth stage, buyouts, spin-offs, and restructurings. The firm also acquires controlling interest. | Finance |
Angiogenix, Inc.
Angiogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic solutions for chronic vascular diseases | Health Technology |
Sierra Oncology, Inc.
Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
TRIA Beauty, Inc.
TRIA Beauty, Inc. Medical SpecialtiesHealth Technology Manufactures and retails hair removal and skincare devices through online | Health Technology |
Aspreva Pharmaceuticals Corp.
Aspreva Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
BioForm Medical, Inc.
BioForm Medical, Inc. Medical SpecialtiesHealth Technology Develops technology for soft and hard tissue augmentation | Health Technology |
Carbylan Therapeutics, Inc.
Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of molecule protease inhibitors | Health Technology |
Ceptaris Therapeutics, Inc.
Ceptaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
APT Pharmaceuticals, Inc.
APT Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug development company | Health Technology |
AirXpanders, Inc.
AirXpanders, Inc. Medical SpecialtiesHealth Technology Develops medical devices for women who require tissue expansion for breast reconstruction | Health Technology |
NextWave Pharmaceuticals, Inc.
NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder | Health Technology |
Minerva Surgical, Inc.
Minerva Surgical, Inc. Medical SpecialtiesHealth Technology Develops medical devices for women's healthcare | Health Technology |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Health Technology |
Health360, Inc.
Health360, Inc. Medical/Nursing ServicesHealth Services Provides health services | Health Services |
Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
Menlo Therapeutics, Inc.
Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of serlopitant products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neomend, Inc.
Neomend, Inc. BiotechnologyHealth Technology Develops surgical wound healing products | Health Technology |
Essentialis, Inc.
Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Health Technology |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
KalVista Pharmaceuticals Ltd.
KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops oral medicines | Health Technology |
Medley Health, Inc.
Medley Health, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing and communications services | Commercial Services |
Biohaven Pharmaceutical Holding Co. Ltd.
Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs to treat neurological and neuropsychiatric diseases | Health Technology |
KalVista Pharmaceuticals, Inc.
KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
Dermatology Innovation Forum | |
Frazier Life Sciences Management LP
Frazier Life Sciences Management LP Investment ManagersFinance Frazier Life Sciences generally seeks long-term capital appreciation through making investments in and creating biopharmaceutical companies in the global healthcare sector and developing novel therapeutics near value inflection points. The firm attempts to employ a disciplined investment style and achieve diversification within the global healthcare sector, with the goal of creating attractive risk-adjusted returns. | Finance |
Kies jouw editie
Alle financiële informatie op nationaal niveau